| A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease B Stansley, J Post, K Hensley Journal of neuroinflammation 9, 1-8, 2012 | 441 | 2012 |
| L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells BJ Stansley, BK Yamamoto Neuropharmacology 67, 243-251, 2013 | 97 | 2013 |
| The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia BJ Stansley, PJ Conn Current opinion in pharmacology 38, 31-36, 2018 | 65 | 2018 |
| l-Dopa and Brain Serotonin System Dysfunction BJ Stansley, BK Yamamoto Toxics 3 (1), 75-88, 2015 | 56 | 2015 |
| Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress ME Joffe, CI Santiago, BJ Stansley, J Maksymetz, RG Gogliotti, JL Engers, ... Neuropharmacology 144, 19-28, 2019 | 53 | 2019 |
| Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus BJ Stansley, BK Yamamoto Journal of Pharmacology and Experimental Therapeutics 351 (2), 440-447, 2014 | 51 | 2014 |
| Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target RG Gogliotti, NM Fisher, BJ Stansley, CK Jones, CW Lindsley, PJ Conn, ... Journal of Pharmacology and Experimental Therapeutics 365 (2), 291-300, 2018 | 45 | 2018 |
| Neuropharmacological insight from allosteric modulation of mGlu receptors BJ Stansley, PJ Conn Trends in pharmacological sciences 40 (4), 240-252, 2019 | 36 | 2019 |
| Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus S Dogra, BJ Stansley, Z Xiang, W Qian, RG Gogliotti, F Nicoletti, ... Biological psychiatry 90 (6), 385-398, 2021 | 33 | 2021 |
| M1 muscarinic receptors modulate fear-related inputs to the prefrontal cortex: implications for novel treatments of posttraumatic stress disorder J Maksymetz, ME Joffe, SP Moran, BJ Stansley, B Li, K Temple, ... Biological psychiatry 85 (12), 989-1000, 2019 | 32 | 2019 |
| Behavioral impairments and serotonin reductions in rats after chronic L-dopa BJ Stansley, BK Yamamoto Psychopharmacology 232, 3203-3213, 2015 | 26 | 2015 |
| Contextual fear extinction induces hippocampal metaplasticity mediated by metabotropic glutamate receptor 5 BJ Stansley, NM Fisher, RG Gogliotti, CW Lindsley, PJ Conn, ... Cerebral Cortex 28 (12), 4291-4304, 2018 | 22 | 2018 |
| VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides CW Reed, KM McGowan, PK Spearing, BJ Stansley, HF Roenfanz, ... ACS Medicinal Chemistry Letters 8 (12), 1326-1330, 2017 | 21 | 2017 |
| mGlu5 Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu5-Endocannabinoid Signaling Z Xiang, X Lv, J Maksymetz, BJ Stansley, A Ghoshal, RG Gogliotti, ... ACS Pharmacology & Translational Science 2 (3), 198-209, 2019 | 19 | 2019 |
| Co-activation of metabotropic glutamate receptor 3 and beta-adrenergic receptors modulates cyclic-AMP and long-term potentiation, and disrupts memory reconsolidation AG Walker, DJ Sheffler, AS Lewis, JW Dickerson, DJ Foster, RK Senter, ... Neuropsychopharmacology 42 (13), 2553-2566, 2017 | 17 | 2017 |
| Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome NM Fisher, RG Gogliotti, SAD Vermudez, BJ Stansley, PJ Conn, ... ACS chemical neuroscience 9 (9), 2210-2217, 2017 | 12 | 2017 |
| A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease. J Neuroinflamm 9: 115 B Stansley, J Post, K Hensley | 8 | 2012 |
| T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION B Stansley, M Joffe, S Yohn, C Lindsley, C Niswender, P Jeffrey Conn Schizophrenia Bulletin 44 (suppl_1), S127-S128, 2018 | 1 | 2018 |
| AL002c‐mediated reduction in amyloid β pathology is reflected by changes in plasma Alzheimer’s disease biomarkers in 5XFAD mice B Burgess, A Ibrahim, B Stansley, T Schwabe, S Wang, M Colonna, ... Alzheimer's & Dementia 19, e072737, 2023 | | 2023 |
| 43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA PJ Conn, S Yohn, B Stansley, D Foster, H Plumley, C Lindsley Schizophrenia Bulletin 44 (suppl_1), S70-S70, 2018 | | 2018 |
